ROCK & ASSOCIATES for US COMPOUNDING
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Budget/Appropriations BUD
Appropriations to fund the FDA implementation of regulations affecting compounding pharmacy and outsourcing facilities.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Pharmacy PHA
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Law Enforcement/Crime/Criminal Justice LAW
Proposals to amend the Controlled Substances Act to clarify the definition of dispense to include the delivery of a controlled substance by a practitioner acting in the usual course of professional practice. No specific legislation yet.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES W ROCK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.